IPM Chirana

What IPM Chirana does

IPM Chirana is a medical device company formed in 2020 as a strategic partnership between IPM Group (a London-headquartered infraTech asset manager) and Chirana Medical (a Slovak medical and dental device manufacturer founded in 1935) to globally scale production of the Aura V critical care ventilator in response to COVID-19-related ICU demand. The company's singular product is the Aura V, a multi-modal mechanical ventilator indicated for adult, pediatric, and neonatal patients, distinguished by its proprietary PMLV® (Programmed Multi-Level Ventilation) mode that uses three pressure levels with differentiated respiratory cycle times and real-time pulmonary mechanics analysis to improve gas distribution in severely affected lungs. Complementary modules include Pulmon (pulmonary mechanics monitoring), MetaMon (metabolic monitoring via indirect calorimetry), and OPTI (automated ventilation parameter adjustment).

The business operates a hardware sales model, selling ventilators directly to hospital ICUs and healthcare providers through an enterprise field sales motion, with manufacturing executed via a partnership with SMTC at its Boston, MA facility (US HQ is in Durham/Research Triangle Park, NC) and through Chirana Medical's existing Slovak operations. The company holds ANVISA emergency marketing authorization in Brazil and has applications under review in the US and Canada, targeting distribution across the Americas, Western Europe, Middle East, Africa, and India. Commercial traction is nascent, with one named hospital installation disclosed (Octavio Quercia Heart Hospital, Brazil, November 2021).

Name

IPM Chirana

Legal name

IPM Chirana Inc.

Website

https://ipmchirana.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

IPM Chirana manufactures and globally distributes the Aura V, a multi-modal critical care ventilator with proprietary PMLV® technology, selling directly to hospital ICUs across the Americas, Western Europe, Middle East, Africa, and India.

Ownership category

akta.pro rank

Product category

Critical Care Ventilators (Medical Devices)

NAICS

Ventilation, Heating, Air-Conditioning, and Commercial Refrigeration Equipment Manufacturing (33341)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro industry

PRIMARYHLAHAGAC

Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices

Keywords

• Critical care ventilators
• Mechanical ventilation systems
• ICU respiratory equipment
• Medical device manufacturing
• Ventilation technology

Headquarters

HQ city

Trnava

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: IPM Chirana generates revenue through the sale of Aura V critical care ventilators to hospitals and healthcare facilities globally.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

IPM Chirana manufactures and globally distributes the Aura V, an advanced critical care ventilator system designed for adult, pediatric, and neonatal patients in hospital ICU settings. The ventilator features proprietary PMLV® (Programmed Multi-Level Ventilation) mode and a comprehensive suite of multi-modal ventilation options (CMV, PCV, SIMV, PS, CPAP, HFloNV, and others) along with real-time pulmonary mechanics and metabolic monitoring. The company was formed as a 2020 strategic partnership between IPM Group and Chirana Medical to scale production of the Aura V ventilator globally in response to critical care ventilator shortages, with manufacturing conducted at the SMTC facility in Boston, MA and Slovak operations.

Product overview

IPM Chirana offers a single unified product—the Aura V critical care ventilator system—designed for intensive care units. The system integrates multiple add-on modules including Pulmon (pulmonary mechanics monitoring), PMLV® (Programmed Multi-Level Ventilation), MetaMon (metabolic monitoring), and OPTI (optimized ventilation). The core Aura V platform provides comprehensive mechanical ventilation with support for adult, pediatric, and neonatal patients, while the proprietary PMLV® technology distinguishes it as a unique capability for severe lung conditions.

Differentiator

Problem solved

Functional benefit

Brands

• Aura V: Advanced critical care ventilator system designed for adult, pediatric, and neonatal patients with multi-modal technology and proprietary PMLV (Programmed Multi-Level Ventilation) mode.

Products and services

• Aura V Critical Care Ventilator Advanced critical care ventilator designed for hospital ICUs treating adult, pediatric, and neonatal patients. Features proprietary PMLV® mode and comprehensive multi-modal ventilation (CMV, PCV, SIMV, PS, CPAP, HFloNV, and others) with integrated pulmonary mechanics (Pulmon), metabolic monitoring (MetaMon), and optimized ventilation (OPTI) capabilities. Targets global hospital procurement for respiratory support of severely ill patients.

Quantifiable outcome

• Designed to lower mortality rates in hospital ICUs through advanced ventilation technology

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• SMTCcoreOEM/ Whitelabel/ Licensing Partner · 1 November 2020SMTC is a manufacturing partner operating a facility in Boston, MA where production of Aura V critical care ventilators commenced in November 2020. SMTC successfully implemented the accelerated production plan, manufacturing at least 300 Aura V ventilators by year-end.
• Chirana MedicalcoreStrategic or Co-development Partner · 1 March 2020Strategic partnership formed in spring 2020 between IPM Group and Chirana Medical, a Slovak company founded in 1935 specializing in medical and dental devices. Chirana brings proprietary Aura V ICU ventilator technology and manufacturing expertise, with products manufactured in Slovakia, Russia, and Uzbekistan. The partnership aims to accelerate global production of the Aura V ventilator.

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Hamilton Medical: Swiss manufacturer of ICU mechanical ventilators (e.g., G5, C6). Direct head-to-head competitor to the Aura V in hospital ICUs, with similar multi-modal ventilation features and global sales coverage.
• Getinge (Maquet): Swedish maker of Servo-u/s and Servo-i critical care ventilators via the Maquet brand. A direct peer to IPM Chirana in advanced ICU ventilation for adult, pediatric, and neonatal patients.
• Dräger: German manufacturer of Evita and Evita Infinity V500 ICU ventilators. Competes directly with Aura V in critical care ventilation and has a long-standing global installed base in hospitals.
• Medtronic (Puritan Bennett): Acquired Covidien and sells the Puritan Bennett 980 and 840 ICU ventilators. One of the largest installed bases in U.S. hospital ICUs and a direct competitor to the Aura V in the same clinical use cases.
• Vyaire Medical: Specialized respiratory care company selling bellavista and other ICU ventilators. A focused competitor to Aura V in mechanical ventilation across global hospital markets.
• Löwenstein Medical: German manufacturer of elisa and LUISA ICU/home ventilators. Direct comparable in the European critical care ventilation market where Aura V is also established.

Broad incumbents

• GE Healthcare (Carescape): Sells Carescape R860 ICU ventilator as part of a broader patient monitoring and anesthesia portfolio. Competes with Aura V in hospital ICUs while serving customers across many other clinical product lines.
• Philips (Respironics): Sells hospital and home ventilation products under Respironics. Overlaps with Aura V in critical and non-invasive ventilation, though the portfolio is much broader and spans sleep and respiratory care.
• ResMed: Global leader in sleep and non-invasive ventilation with a growing hospital ventilation portfolio. Competes with Aura V in invasive and non-invasive respiratory care, primarily across respiratory and ICU use cases.

Emerging players

• Mindray: Chinese medical device company with a growing line of SV300/SV600/SV800 ICU ventilators. Increasingly competes with Aura V in cost-sensitive emerging markets across Asia, Latin America, and the Middle East.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ipm-chirana

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IPM Chirana